Consternation about the Ohio budget is trumped only by the belief in so many corners of the state that this final budget will need to be revised in a matter of months.
Even after the governor’s signature today, it’s hard to discern what the state’s two-year fiscal plan means for health care. Mental health, medical durable goods and many hospitals are still crunching numbers but expecting the worst. It will also be interesting to see if the state’s life-science industry can capitalize on the budget’s perceived positives: keeping critical economic incentives even as other states cut back on theirs and the venture capital industry struggles.
This was a week full of potential and perceptions. Here are some other worthwhile items from the past five days. Have a great weekend.
- Cleveland Clinic opened for business in Las Vegas and also started to reassigning duties in the wake of its departing executives. Still unaddressed: emerging business.
- Medical students take a stand to maintain the status quo and protect the white doctor’s coat.
- A Minnesota legislator will reintroduce economic incentives to help that state’s startups.
- One of Cleveland’s newest medical device CEOs is honored in Washington, D.C.
- Things are looking up for a Michigan biotech developing an osteoporosis drug with the help of black bears. But things weren’t so great for Minnesota’s Biotel, which is picking up the pieces after an acquisition agreement fell through.
[Photo courtesy of Flickr user aflcio2008]